Brian Armstrong Denies Lobbying on Bitcoin Tax Break
Coinbase CEO Brian Armstrong refutes accusations of lobbying against a Bitcoin de minimis tax exemption as lawmakers ...
Ways To Boost Credit Card Points
Explore various ways to boost your credit card points effectively. Enhance your earnings and enjoy greater rewards.
18,527 articlesBest Stock Invest $500: Smart Picks for Your Small Portfolio
Got $500 to invest? This guide breaks down a practical plan to pick the best stock invest $500, with a simple framewo...
Should (Ripple) Below $1.50? A Practical XRP Investing Guide
The crypto market has questions about XRP at sub-$1.50 levels. This guide weighs the risks and potential rewards, off...
Intel’s Completed First Year: Signals of Rebound and Risk
One year into Lip-Bu Tan’s tenure, Intel trimmed costs, pushed 18A production forward, and rebuilt the balance sheet—...
E.L.F. Beauty Shares Down: Two Key Reasons for the Drop
e.l.f. beauty shares down have caught the attention of investors as momentum slows and margins feel pressure. This ar...
This Insider Sold 1,000 Shares: Signals and Implications
Insider trading activity can reveal how executives view their company’s future. This article digs into a real-world c...
Fed’s Waller Says Doesn’t Back Rate Hikes, Inflation Cooling
Federal Reserve Governor Christopher Waller signaled that he does not support additional rate hikes for now and expec...
Is the Stock Market Sending Warning About AI Stocks
As AI hype cools and traditional earnings prove steadier, the market posture may be sending subtle signals. This arti...
Tesla Rivian: Which Stock Will Outperform the Market in 2026
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...
Baozun (BZUN) 2025 Earnings: Key Insights and Outlook
Baozun's baozun (bzun) 2025 earnings signal shifts in China’s DTC ecosystem. This article breaks down Q4 results, mar...
Stock Market Live March 26, 2026: SPY Slips on Oil
Oil-driven weakness pushed the S&P 500 lower in a volatile March session. SPY skidded as energy names led declines, w...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status